Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
White Matter Changes in Patients with Friedreich Ataxia after Treatment with Erythropoietin.
EBV & HHV6 reactivation is infrequent and not associated with MS clinical course.
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
Transverse Myelitis.
Methods for identifying subject-specific abnormalities in neuroimaging data.
Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism.
Ultra-high-field MR imaging in multiple sclerosis.
Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway.
Studies in Experimental Autoimmune Encephalomyelitis Do Not Support Developmental Bisphenol A Exposure as an Environmental Factor in Increasing Multiple Sclerosis Risk.
The Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation.
Monitoring game-based motor rehabilitation of patients at home for better plans of care and quality of life.
IL-25 prevents T cell-mediated neurotoxicity by decreasing LFA-1 expression.
Age of the Donor Reduces the Ability of Human Adipose-Derived Stem Cells to Alleviate Symptoms in the Experimental Autoimmune Encephalomyelitis Mouse Model.
Sphingosine-1 phosphate and central nervous system.
Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
IgM-monoclonal gammopathy neuropathy and tremor: A first epidemiologic case control study.
Pediatric familial neuromyelitis optica in two sisters with long term follow-up.
What do multiple sclerosis patients and their caregivers perceive as unmet needs?
Bedside tested ocular motor disorders in multiple sclerosis patients.
Energy expenditure during everyday activities - a study comparing people with varying mobility limitations due to multiple sclerosis and healthy controls.
C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica.
Prevalence of multiple sclerosis in Brazil: A systematic review.
The importance of IL-33 in allergic inflammation.
Venous endothelial injury in central nervous system diseases.
GCN2 kinase plays an important role triggering the remission phase of experimental autoimmune encephalomyelitis (EAE) in mice.
Pages
« first
‹ previous
…
482
483
484
485
486
487
488
489
490
…
next ›
last »